RxDoctor Payments DataLook up a doctor →

Randall Carlton, MD

Family Medicine · Jonesboro, ARNPI 1295791523

Payments from drug & device makers

$12,755in general payments, 2019–2025

Across 893 payments — averaging $14.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$2K
  • Pfizer$1K
  • Novo Nordisk$1K
  • Lilly USA, LLC$902
  • Amgen$628
  • plus $5K from 48 others

What the payments were for

  • Food & beverage$12,755100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,755 in reported general payments places this provider in the 95th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$119,377
Medicare patients
314
Services billed
2,470

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban98$69,745
Trelegy ElliptaFluticasone/Umeclidin/Vilanter34$27,127
OzempicSemaglutide19$19,001
JardianceEmpagliflozin27$16,295
JanumetSitagliptin Phos/Metformin Hcl13$13,979
TrulicityDulaglutide11$13,379
JanuviaSitagliptin Phosphate19$10,576
MyrbetriqMirabegron20$9,330
Tresiba Flextouch U-200Insulin Degludec14$5,600
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog12$4,416
Lantus SolostarInsulin Glargine,hum.Rec.Anlog24$3,429
SynthroidLevothyroxine Sodium50$3,348
Omeprazole198$2,614
Atorvastatin Calcium244$2,105
Pantoprazole Sodium170$2,021

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$1,444$69,74598 claims
GSKTrelegy Ellipta$296$27,12734 claims
MerckJanumet, Januvia$420$24,55532 claims
Novo NordiskOzempic$1,216$19,00119 claims
Boehringer IngelheimJardiance$199$16,29527 claims
Lilly USA, LLCTrulicity$902$13,37911 claims
Astellas Pharma US IncMyrbetriq$331$9,33020 claims
AbbVieSynthroid$1,831$3,34850 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Jonesboro

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →